Literature DB >> 12928286

Late and very late initial probing for congenital nasolacrimal duct obstruction: what is the cause of failure?

M B Kashkouli1, B Beigi, M M Parvaresh, A Kassaee, Z Tabatabaee.   

Abstract

AIMS: To find the cure rate of late (second year of age) and very late (3-5 years of age) initial probing for congenital nasolacrimal duct obstruction (CNLDO) and to identify the factors contributing to the failure rate of the probing in older children.
METHODS: In a prospective interventional case series study, 169 eyes of 125 consecutive patients (1-5 years old) with CNLDO underwent probing under general anaesthesia. Cure was defined as absence of tearing and discharge in the affected eye.
RESULTS: 138 eyes of 101 patients aged 13-60 months (mean 23.4 (SD 10.2)) were included. Of 15 eyes (10.8%) with complex CNLDO, 80% presented after 24 months of age (p<0.0001). The cure rate was 89% in patients 13-24 months of age and 72% after the age of 24 months (p = 0.01). It was 90.2% in the membranous and 33.3% in the complex CNLDO in both late and very late probing (p<0.0001). There was a high correlation (r = 0.97) and no significant difference between the cure rate at 1 week and final follow up.
CONCLUSION: Accumulation of the complex CNLDO is the main risk factor for failure of probing in the older children. The outcome of the nasolacrimal duct probing at 1 week follow up is highly indicative of the final outcome.

Entities:  

Mesh:

Year:  2003        PMID: 12928286      PMCID: PMC1771862          DOI: 10.1136/bjo.87.9.1151

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  Value of nasal endoscopy and probing in the diagnosis and management of children with congenital epiphora.

Authors:  C J MacEwen; J D Young; C W Barras; B Ram; P S White
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

2.  The management of nasolacrimal duct obstruction in children between 18 months and 4 years old.

Authors:  B J Kushner
Journal:  J AAPOS       Date:  1998-02       Impact factor: 1.220

3.  Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.

Authors:  G E Mannor; G E Rose; K Frimpong-Ansah; E Ezra
Journal:  Am J Ophthalmol       Date:  1999-05       Impact factor: 5.258

4.  Medical management of congenital nasolacrimal duct obstruction.

Authors:  L R Nelson; J H Calhoun; H Menduke
Journal:  Ophthalmology       Date:  1985-09       Impact factor: 12.079

5.  Results of late probing for congenital nasolacrimal duct obstruction.

Authors:  J el-Mansoury; J H Calhoun; L B Nelson; R D Harley
Journal:  Ophthalmology       Date:  1986-08       Impact factor: 12.079

6.  Timing of initial probing and irrigation in congenital nasolacrimal duct obstruction.

Authors:  J A Katowitz; M G Welsh
Journal:  Ophthalmology       Date:  1987-06       Impact factor: 12.079

7.  Intranasal endoscopic diagnosis and treatment in congenital nasolacrimal duct obstruction.

Authors:  Woong C Choi; Kyu S Kim; Tae K Park; Chun Suk Chung
Journal:  Ophthalmic Surg Lasers       Date:  2002 Jul-Aug

8.  Treatment of congenital nasolacrimal system obstruction.

Authors:  J D Baker
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1985 Jan-Feb       Impact factor: 1.402

9.  Systematic, combined treatment approach to nasolacrimal duct obstruction in different age groups.

Authors:  F Ciftçi; A Akman; M Sönmez; M Unal; A Güngör; V Yaylali
Journal:  Eur J Ophthalmol       Date:  2000 Oct-Dec       Impact factor: 1.922

10.  Conventional or endoscopic probing for congenital nasolacrimal duct obstruction.

Authors:  M Orhan; P Cal; M Onerci; M Irkeç
Journal:  Eur J Ophthalmol       Date:  2001 Jul-Sep       Impact factor: 1.922

View more
  34 in total

1.  [Increased prevalence of congenital dacryostenosis following cesarean section].

Authors:  Claudia Kuhli-Hattenbach; M Lüchtenberg; C Hofmann; T Kohnen
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

Review 2.  [Current aspects on treatment of congenital dacryostenosis].

Authors:  J Heichel; H G Struck
Journal:  Ophthalmologe       Date:  2015-07       Impact factor: 1.059

3.  Balloon dacryoplasty: ushering the new and routine era in minimally invasive lacrimal surgeries.

Authors:  Mohammad Javed Ali; Milind N Naik; Santosh G Honavar
Journal:  Int Ophthalmol       Date:  2012-10-17       Impact factor: 2.031

4.  Success rates of dacryoendoscopy-guided probing for recalcitrant congenital nasolacrimal duct obstruction.

Authors:  Masahiro Fujimoto; Ken Ogino; Hiroko Matsuyama; Chika Miyazaki
Journal:  Jpn J Ophthalmol       Date:  2016-04-27       Impact factor: 2.447

5.  Probing for congenital nasolacrimal duct obstruction in older children.

Authors:  Bahram Eshragi; Masoud Aghsaei Fard; Babak Masomian; Mohammadreza Akbari
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

6.  A symptom survey and quality of life questionnaire for nasolacrimal duct obstruction in children.

Authors:  Jonathan M Holmes; David A Leske; Stephen R Cole; Danielle L Chandler; Michael X Repka; David I Silbert; David Robbins Tien; Elizabeth A Bradley; Nicholas A Sala; Erika M Levin; Darren L Hoover; Deborah L Klimek; Brian G Mohney; Daniel M Laby; Katherine A Lee; Robert W Enzenauer; Darron A Bacal; Monte D Mills; Roy W Beck
Journal:  Ophthalmology       Date:  2006-07-07       Impact factor: 12.079

7.  Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years.

Authors:  Michael X Repka; Danielle L Chandler; Roy W Beck; Eric R Crouch; Sean Donahue; Jonathan M Holmes; Katherine Lee; Michele Melia; Graham E Quinn; Nick A Sala; Susan Schloff; David I Silbert; David K Wallace
Journal:  Ophthalmology       Date:  2007-11-08       Impact factor: 12.079

8.  Acquired nasolacrimal duct obstruction in children.

Authors:  Kyu Mee Kay; Kyung In Woo; Jung Hoon Kim; Hae Ran Chang
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

9.  Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age.

Authors:  Michael X Repka; B Michele Melia; Roy W Beck; Danielle L Chandler; Deborah R Fishman; Todd A Goldblum; Jonathan M Holmes; Bernard D Perla; Graham E Quinn; David I Silbert; David K Wallace
Journal:  J AAPOS       Date:  2008-10       Impact factor: 1.220

10.  Primary treatment of nasolacrimal duct obstruction with nasolacrimal duct intubation in children younger than 4 years of age.

Authors:  Michael X Repka; B Michele Melia; Roy W Beck; C Scott Atkinson; Danielle L Chandler; Jonathan M Holmes; Alexander Khammar; David Morrison; Graham E Quinn; David I Silbert; Benjamin H Ticho; David K Wallace; David R Weakley
Journal:  J AAPOS       Date:  2008-07-02       Impact factor: 1.220

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.